Activators of STING, including ADU-S100, DMXAA and 3’3’-cGAMP, have been shown to reverse CIPN-, nerve injury- (22) and bone cancer-induced pain in mice (23) via suppression of nociceptor excitability. Here, STING1 is linked to bone cancer.